Status:

RECRUITING

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

Lead Sponsor:

N-Power Medicine

Conditions:

Cancer

Eligibility:

All Genders

18-120 years

Brief Summary

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surv...

Detailed Description

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surv...

Eligibility Criteria

Inclusion

  • Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent

Exclusion

  • Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative

Key Trial Info

Start Date :

August 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2099

Estimated Enrollment :

20000 Patients enrolled

Trial Details

Trial ID

NCT06877884

Start Date

August 1 2022

End Date

January 1 2099

Last Update

October 20 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Pacific Cancer Care

Monterey, California, United States, 93940

2

Bayhealth Cancer Center-Kent

Dover, Delaware, United States, 19901

3

Bayhealth Cancer Center- Sussex

Milford, Delaware, United States, 19963

4

Northwest Oncology & Hematology

Elk Grove Village, Illinois, United States, 60007

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data | DecenTrialz